RTT-associated mutations in the TRD, such as the missense variant p.R306C (Table 2), disrupt MeCP2’s binding to the NCoR1/2 complex, suggesting that disruption of this interaction plays an important role in RTT pathogenesis [43]. This evidence concerns the gene MECP2 and Rett syndrome.